The role of monoamines in the development of Alzheimer's disease and neuroprotective effect of a proline rich polypeptide

Progress in Neuro-psychopharmacology & Biological Psychiatry
Konstantin YenkoyanMichail Aghajanov

Abstract

We have analyzed the alterations in the brain monoaminergic system using the rat model of AD-like pathology. In addition, we have investigated potential neuroprotective effects of the hypothalamic proline-rich polypeptide (PRP-1). Histochemical staining, HPLC, chemiluminescent and bioluminescence assays. The levels of monoamines in the target AD brain structures were found elevated, except serotonin, which was unaffected in both hippocampus and brainstem and decreased in frontal cortex. This was accompanied by the substantial structural damage of cortical, hippocampal, as well as the monoaminergic neurons of locus coeruleus and oxidative stress. PRP-1 was able to reverse most of these changes. The increased levels of major brain monoamines in the model of AD supports the hypothesis of the important role of monoamines in the excessive synaptic excitation resulting in cognitive dysfunction in AD brain. The neuroprotective effect of PRP-1 as manifested by the recovery of monoaminergic system suggests this bioactive compound as a perspective therapeutic agent for the treatment of AD.

References

Jan 1, 1987·Annual Review of Neuroscience·S L Foote, J H Morrison
Jan 1, 1995·The American Journal of Psychiatry·R MigliorelliS E Starkstein
Apr 24, 1997·Annals of the New York Academy of Sciences·S M Waters, T P Davis
Feb 24, 2001·The Journal of Neuropsychiatry and Clinical Neurosciences·K L LanctôtP Mazzotta
Apr 7, 2004·Cell·Charles F MurchisonSteven A Thomas
Jun 19, 2004·Neurochemical Research·A A GaloyanH G Vahradyan
Feb 27, 2007·European Journal of Pharmacology·Christian HolscherHanspeter A Mallot
Jul 17, 2007·Progress in Neuro-psychopharmacology & Biological Psychiatry·A GladkevichM Aghajanov
Jul 31, 2007·Journal of Chemical Neuroanatomy·Jahn N O'NeilKebreten F Manaye
Dec 13, 2007·Nature Reviews. Neuroscience·Robert DantzerKeith W Kelley
Dec 19, 2008·The Journal of Neuroscience : the Official Journal of the Society for Neuroscience·Ying LiuMichael K Lee
Aug 18, 2009·Neuropathology and Applied Neurobiology·G SimicP R Hof
Aug 16, 2011·Brain Research Bulletin·Konstantin YenkoyanMichail Aghajanov
Aug 9, 2012·Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism·Lane K BekarMaiken Nedergaard
Mar 8, 2013·Depression and Anxiety·Andrew H MillerJennifer C Felger
May 28, 2013·Neuroscience and Biobehavioral Reviews·Ludwig TrilloAhmad Salehi
Feb 18, 2016·Neural Plasticity·Bianca SeifertTanja Brigadski

❮ Previous
Next ❯

Related Concepts

Related Feeds

Alzheimer's Disease: Amyloid Beta

Alzheimer's disease is a neurodegenerative disease associated with the accumulation of amyloid plaques in the brain; these plaques are comprised of amyloid beta deposits. Here is the latest research in this field.